comparemela.com

Latest Breaking News On - Hetero group of companies - Page 1 : comparemela.com

Meet India s richest MP, part of family with Rs 39200 crore wealth, 4th richest pharma tycoon, his net worth is…

Dr B Partha Saradhi Reddy draws his massive wealth from investment and stake in the Hetero Group of Companies which he leads as the Chairman.

Bharat rashtra samithiB partha saradhi reddyRajya sabhaHetero group of companiesMember of parliamentOsmania university of hyderabadHetero groupSynthetic organic chemistryNorganic chemistryOsmania universityHurun india rich listHyderabad basedb partha saradhi reddyIchest mpRichest politicianIchest rajya sabha mpHetero group

Banapuram to Burma, a journey

Former Ambassador High Commissioner G Parthasarathy shared anecdotes from his interactions with the author during their diplomatic service.

Andhra pradeshOsmania universityJusticep madhavi deviAvula bhaskar reddyB parthasarathi reddyBhaskar reddyTelanagana golf associationTelangana high courtScience collegeNews serviceHetero group of companiesDaspalla hotel in jubilee hillsIncome tax departmentExpress newsDaspalla hotelPresident telanagana golf

Hetero s Nirmacom is world s first generic version of COVID-19 oral drug PAXLOVID to receive WHO Prequalification

27.12.2022 - Hetero s Nirmacom (Nirmatrelvir), a generic version of Pfizer s COVID-19 oral antiviral drug PAXLOVID is co-packaged with ritonavir tabletsWith the launch of Nirmacom, Hetero aims to expand access of the ground-breaking antiviral in 95 LMICs .

Charles goreVamsi krishna bandiHetero group of companiesManaging directorHetero groupMedicines patent poolExecutive director

Hetero s Nirmacom World s 1st Generic Covid Oral Drug Paxlovid to Get WHO Pre-qualification

Hetero, India’s leading pharmaceutical company with the widest global reach, today announced the receipt of World Health Organization Prequalification of Medicines Program (WHO PQ) approval for its generic version of COVID-19 oral antiviral treatment candidate nirmatrelvir. This is the first prequalification for a generic version of Pfizer’s COVID-19 oral antiviral drug

Charles goreVamsi krishna bandiHetero group of companiesWorld health organization prequalification of medicines programWorld health organization prequalificationMedicines programManaging directorHetero groupMedicines patent poolExecutive directorEmergency use authorizationDrugs controller generalHetero 039s nirmacomEtero 039s nirmacom world 1st generic covid oral drugEtero 039s nirmacom paxlovid to get who pre qualification

Welcome To IANS Live - NATION - Hetero s Covid-19 oral drug gets WHO pre-qualification

This is the first pre-qualification for a generic version of Pfizer s Covid-19 oral antiviral drug Paxlovid , which the WHO called, the best therapeutic choice for high-risk patients to date.WHO

Andhra pradeshCharles goreVamsi krishna bandiHetero group of companiesWorld health organization prequalification of medicines programmeWorld health organization prequalificationMedicines programmeManaging directorHetero groupMedicines patent poolMiddle income countriesExecutive directorEmergency use authorizationDrugs controller general

vimarsana © 2020. All Rights Reserved.